MED1 and neoplasm: These authors proposed an epigenetic explanation for BED inhibitor resistance in TNBC cells, whereby the PP2A tumour suppressor gene is inactivated, leading to hyperphosphorylated BRD4 which binds more strongly to MED1 and allows for bromodomain-independent chromatin recruitment [40].